GT Biopharma, Inc. (GTBP)
NASDAQ: GTBP · Real-Time Price · USD
6.68
+0.72 (12.08%)
At close: Oct 9, 2026, 4:00 PM EDT
6.80
+0.12 (1.80%)
After-hours: Oct 9, 2026, 7:56 PM EDT
GT Biopharma Market Cap
GT Biopharma has a market cap or net worth of $12.05 million as of October 9, 2026. It is the 40,553rd most valuable company in the world and the 5,529th biggest in the United States. Its market cap has increased by 217.19% in one year.
Market Cap
12.05M
Enterprise Value
7.09M
1-Year Change
217.19%
Global Rank
Country Rank
#5,529 United States
Category
ChartMarket Cap Chart
Since March 27, 2018, GT Biopharma's market cap has decreased from $83.20M to $12.05M, a decrease of -85.51%. That is a compound annual growth rate of -20.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 12.10M | 45.78% |
| Dec 31, 2025 | 8.30M | 22.06% |
| Dec 31, 2024 | 6.80M | -35.85% |
| Dec 29, 2023 | 10.60M | -63.19% |
| Dec 30, 2022 | 28.80M | -69.13% |
| Dec 31, 2021 | 93.30M | 181.02% |
| Dec 31, 2020 | 33.20M | 503.64% |
| Dec 31, 2019 | 5.50M | -83.13% |
| Dec 31, 2018 | 32.60M | -60.82% |
| Mar 27, 2018 | 83.20M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pluri | 11.93M |
| BioLineRx | 11.91M |
| Intensity Therapeutics | 11.88M |
| Niki BioSolutions | 11.75M |
| Daré Bioscience | 11.73M |
| Passage Bio | 11.65M |
| Phio Pharmaceuticals | 11.29M |
| Lantern Pharma | 10.60M |